We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Systems Biology Used To Study Cellular Glycomics in White Blood Cells

By LabMedica International staff writers
Posted on 12 Nov 2008
Print article
Two recent papers have presented the results of attempts to use a systems biology approach to understand the cellular glycome. The glycome represents a cell's total sugar or carbohydrate composition. It has been described as exceeding the complexity of the proteome because of the even greater diversity of the glycome's constituent carbohydrates, and is further complicated by the sheer multiplicity of possibilities in the combination and interaction of the carbohydrates with each other and with proteins.

Systems biology is a mathematical and experimental approach that focuses on whole systems of complex biological functions and interactions instead of studying individual units, such as a single gene or protein, in isolation. Investigators at the University at Buffalo (NY, USA) used this approach to examine the relationship between gene expression, glycosyltransferase activity, glycan expression, and selectin-binding function in different cell systems, including human neutrophils, undifferentiated HL-60 (human promyelocytic cells), differentiated HL-60, and HL-60 synchronized in specific growth phases. Selectins are a large family of membrane proteins that bind oligosaccharides on other cells tightly and specifically, and are involved in signal transduction across the plasma membrane.

Their results were published in two papers. The first article, which appeared in the August 26, 2008, online edition of The FASEB Journal, described the experimental techniques used to measure enzyme reaction rates involved in glycosylation, and then drew critical correlations with gene expression, enzyme kinetics, and the structures of glycans. The second paper, which was published in the October 7, 2008, online edition of the journal Bioinformatics, described a computer model that utilized the data produced by those experiments to establish a basis for predicting the structures of glycans on cell surfaces.

"Our goal is to find ways to alter carbohydrate structures or glycans on the surfaces of white blood cells,” explained senior author Dr. Sriram Neelamegham, professor of chemical and biological engineering at the University of Buffalo. "Systems biology is well suited to this research because it helps us develop the mathematical concepts to enable us to influence and enhance our understanding of how the glycome functions. This then produces clues on how we might manipulate the adhesivity of white blood cells to the blood vessel wall.”

"The data produced experimentally allows us to determine key steps in the glycome reaction network that controls the final glycan structure that appears on cells,” said Dr. Neelamegham. "This approach then provides an in silico tool that can be applied to perturb the system of interest, such as the glycosylation network.”

Related Links:
State University of New York, University at Buffalo

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.